Exploration Capital, LLC's Form 4 filing
Fresh Tracks Therapeutics, Inc. (FRTX) · filed Apr 11, 2024
- Accession no.
- 0001213900-24-032240
- Filed
- Apr 11, 2024
- Trade date
- Apr 9-10, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $2.81K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Exploration Capital, LLCCIK 0002003514 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2024 | Common Stock | PPurchaseAcquired | +2,188 | $0.88 | +$1,925.44 | 1,038,279 | Direct | |
| Apr 10, 2024 | Common Stock | PPurchaseAcquired | +1,000 | $0.88 | +$880 | 1,039,279 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.